Is the Polynovo share price set to crash in 2020?

The Polynovo Ltd (ASX:PNV) share price is up 350% in the last 12 months – but is it set to soar higher or crash out in 2020?

a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Polynovo Ltd (ASX: PNV) share price has had a strong run to start the year.

Shares in the medical technology group are up 69.35% since just the start of January. If we take that back to 12 months ago, PolyNovo shares are up 350% as one of the top-performing S&P/ASX 200 Index (INDEXASX: XJO) companies.

So, why are shares in this group rocketing higher and is there time to buy and cash in on the growth?

Why PolyNovo shares have surged higher this year

PolyNovo specialises in the development of biodegradable medical devices to aid in tissue repair.

The Aussie healthcare group owes much of its recent share price growth to strong results from its NovoSorb BTM product. The product is a synthetic polymer matrix that clinicians can use to treat serious burn victims.

PolyNovo has experienced strong sales growth in recent times and cracked the $2 million monthly sales mark in December 2019.

Operational expansion and entry into new markets have also been key. PolyNovo is looking to roll out its NovoSorb BTM product across several lucrative European markets.

Polynovo shares have been rocketing higher in 2020 but are trading near an all-time high, so is there time to buy?

Is now the time to buy for growth?

PolyNovo shares have clearly delivered for shareholders in recent times, but that's not always everything.

Personally, I like to invest in companies with strong cash flow and diversified earnings like Fortescue Metals Group Limited (ASX: FMG) or CSL Limited (ASX: CSL).

PolyNovo isn't a dividend-paying share (yet) and is near the top of its valuation cycle. That doesn't mean it's overvalued, but I do think it adds some risk.

We've seen some other hot growth shares like WiseTech Global Ltd (ASX: WTC) and Nearmap Ltd (ASX: NEA) crash lower in recent months. While PolyNovo isn't a pure ASX tech share, and could rocket higher this year, one slip-up on growth could send its shares plummeting.

Kenneth Hall has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of CSL Ltd. The Motley Fool Australia owns shares of and has recommended Nearmap Ltd. The Motley Fool Australia owns shares of WiseTech Global. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Healthcare Shares

a biomedical researcher sits at his desk with his hand on his chin, thinking and giving a small smile with a microscope next to him and an array of test tubes and beackers behind him on shelves in a well-lit bright office.
Healthcare Shares

Broker says this ASX 200 biotech stock is a top buy

Let's see what Bell Potter is saying about this biotech.

Read more »

Cropped shot of an attractive young female scientist working on her computer in the laboratory.
Healthcare Shares

Why CSL shares are a buy today despite the looming Trump tariffs

A leading expert believes CSL shares are still trading for a bargain today. Here's why.

Read more »

A businesswoman pulls her glasses down in shock to look at the bad news on her computer.
Healthcare Shares

Why did the Telix share price just crash 16%?

Investors are sending the Telix share price plunging today. But why?

Read more »

Broker analysing the share price.
Healthcare Shares

Expert: 2 ASX healthcare stocks to avoid before reporting season

Not all healthcare stocks are created equal.

Read more »

A group of people in a corporate setting do a collective high five.
Healthcare Shares

Should I buy Pro Medicus or CSL shares ahead of earnings season?

The ASX healthcare sector may be currently undervalued.

Read more »

Overjoyed man celebrating success with yes gesture after getting some good news on mobile.
Healthcare Shares

Why Mesoblast shares can keep storming higher

More big returns could be on the way for buyers of this high risk stock according to Bell Potter.

Read more »

Doctor doing a telemedicine using laptop at a medical clinic
Healthcare Shares

The Mesoblast share price just rocketed 38%! Here's why

ASX investors just sent the Mesoblast share price up 38%. But why?

Read more »

couple having a happy discussion with a banker
Healthcare Shares

Expert: 4 ASX healthcare stocks to buy ahead of reporting season

Could these ASX healthcare stocks be good additions to your portfolio?

Read more »